✦ LIBER ✦

Inhaled tobramycin nebulizer solution for treatment of early Pseudomonas aeruginosa infection: the ELITE study

✍ Scribed by F. Ratjen; S. Stenglein; A. Munck

Book ID: 118641536
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 61 KB
Volume: 7
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(08)60098-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

100 Safety of inhaled tobramycin nebulis

100 Safety of inhaled tobramycin nebuliser solution for treatment of early Pseudomonas aeruginosa infection: First results from the ELITE study

✍ E. Ratjen; A. Munck; V. Campello 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Treatment of early Pseudomonas aeruginos

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial

✍ Ratjen, F.; Munck, A.; Kho, P.; Angyalosi, G. 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 295 KB

Placebo-controlled, double-blind, random

Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

✍ Heinz Georg Wiesemann; Gratiana Steinkamp; Felix Ratjen; Adolf Bauernfeind; Barb 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

In chronic Pseudomonas aeruginosa pulmonary infection of patients with cystic fibrosis (CF), antibiotic therapy generally fails to eradicate the bacterial pathogen. The mucoid bacterial phenotype, high sputum production by the host, and low airway levels of antibiotics seem to be responsible for the

WS7.5 Prolonged improvement in lung func

WS7.5 Prolonged improvement in lung function and quality of life in cystic fibrosis: a 24-week extension study of levofloxacin nebulization solution (APT-1026) versus tobramycin nebulization solution in stable CF patients with chronic Pseudomonas aeruginosa infection

✍ Elborn, J.S.; Flume, P.A.; Loutit, J.; Cohen, F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Budget Impact Analysis Of The Use Of Tob

Budget Impact Analysis Of The Use Of Tobramycin Inhalation Powder (TIP) For The Treatment Of Chronic Pseudomonas Aeruginosa (PA) Infection In Patients With Cystic Fibrosis Aged ≥ 6 Years In Mexico

✍ Lemus, A.; Rosas, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Inhaled antibiotics for the treatment of

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials

✍ Máiz, Luis; Girón, Rosa M; Olveira, Casilda; Quintana, Esther; Lamas, Adelaida; 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 250 KB